Citadel Advisors - TETRAPHASE PHARMACEUTICALS I ownership

TETRAPHASE PHARMACEUTICALS I's ticker is and the CUSIP is 88165N905. A total of 3 filers reported holding TETRAPHASE PHARMACEUTICALS I in Q2 2015. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Citadel Advisors ownership history of TETRAPHASE PHARMACEUTICALS I
ValueSharesWeighting
Q1 2016$122,000
-45.5%
26,400
+18.4%
0.00%
Q4 2015$224,000
+135.8%
22,300
+75.6%
0.00%
Q3 2015$95,000
-72.2%
12,700
+76.4%
0.00%
Q2 2015$342,000
+245.5%
7,200
+166.7%
0.00%
Q1 2015$99,000
-81.8%
2,700
-80.3%
0.00%
-100.0%
Q4 2014$544,00013,7000.00%
Other shareholders
TETRAPHASE PHARMACEUTICALS I shareholders Q2 2015
NameSharesValueWeighting ↓
GROUP ONE TRADING, L.P. 17,300$821,0000.01%
SIMPLEX TRADING, LLC 46$33,0000.00%
Citadel Advisors 7,200$342,0000.00%
View complete list of TETRAPHASE PHARMACEUTICALS I shareholders